CLAIRE WATTIER: Open Payments
NPI 1518645886 · ABERDEEN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,646 in 124 payments from 19 companies in 2025. Trend: 2023 $283 · 2024 $1,938 · 2025 $2,646
Food & beverage: $2,537Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $523 |
| Regeneron Healthcare Solutions, Inc. | 9 | $285 |
| ABBVIE INC. | 17 | $256 |
| Novartis Pharmaceuticals Corporation | 14 | $253 |
| Lilly USA, LLC | 13 | $241 |
| UCB, Inc. | 11 | $228 |
| GENZYME CORPORATION | 12 | $199 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $172 |
| Amgen Inc. | 6 | $140 |
| Galderma Laboratories, L.P. | 5 | $83 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, ILUMYA, COSENTYX, EBGLYSS, OTEZLA.
Industry payments across SD — which companies pay providers there.
